Arthritis drug may reduce mortality in hospitalised COVID-19 patients - The Pharmaceutical Journal
Adding the rheumatoid arthritis drug, baricitinib, to another immunomodulatory treatment reduces the risk of death in hospitalised patients with severe COVID-19, the results from a major study suggest. Data from the ‘Randomised evaluation of COVID-19 therapy’…
Adding the rheumatoid arthritis drug, baricitinib, to another immunomodulatory treatment reduces the risk of death in hospitalised patients with severe COVID-19, the results from a major study sugges… [+3552 chars]
Read More
Other Stories in Health
- 4 Zodiac Signs On A Love Rollercoaster This Mercury Retrograde
- Eating more fruits and vegetables may help prevent falls in older adults, especially women
- India has a chance to lead in health space amid Global North's funding cuts: Gates Foundation CEO Mark Suzman
- White wine vs. red wine: Which poses a greater cancer risk?
- Better heart health slows brain aging and lowers dementia risk, study finds
- 8 foods to keep your kidneys healthy
- White wine vs. red wine: Which poses a greater cancer risk?
- Better heart health slows brain aging and lowers dementia risk, study finds
- 8 foods to keep your kidneys healthy
.png)
